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ABSTRACT 
Ischemia reperfusion (IR) injury is a significant cause of morbidity and mortality in liver transplantation. When 
oxygen is reintroduced to the liver graft it initiates a cascade of molecular reactions leading to the release of reac-
tive oxygen species (ROS) and pro-inflammatory cytokines. These soluble mediators propagate a sterile immune 
response to cause significant tissue damage. Ischemic preconditioning (IPC) is one method that reduces hepato-
cellular injury by altering the immune response and inhibiting the production of ROS. Studies quantifying the 
effects of IPC in humans have demonstrated an improved liver enzyme panel in patients receiving grafts pretreated 
with IPC as compared to patients receiving the standard of care. In our review, we explore current literature in the 
field in order to describe the mechanism through which IPC regulates the production of ROS and improves IR 
injury.  
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INTRODUCTION 
Reactive oxygen species (ROS) and oxi-
dant stress are the most significant pathologic 
mediators of ischemia reperfusion (IR) injury 
(Jaeschke et al., 2012). It is postulated that 
limiting the amount of ROS produced during 
reperfusion would significantly benefit pa-
tients undergoing liver transplantation, liver 
resection, or other procedures that cause is-
chemia reperfusion injury. Ischemia reperfu-
sion injury is considered a major cause of pri-
mary graft non-function following liver trans-
plantation, and primary graft non-function is 
characterized by high rates of mortality 
(Lemasters and Thurman, 1995; Ploeg et al., 
1993; Strasberg et al., 1994). Liver transplan-
tation ischemia is a type of cold ischemia, 
where the organ lacking blood flow is simul-
taneously cooled during ischemia. The result-
ant ischemia reperfusion injury is character-
ized by detachment of the sinusoidal endothe-
lial cells (SECs), which may be caused by ac-
tin disassembly and activation of matrix met-
alloproteinases (MMPs) (Clavien et al., 1992; 
Upadhya et al., 1997; Upadhya and Strasberg, 
2000). Although SECs remain alive during 
periods of cold ischemia, they experience ac-
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celerated apoptosis during oxygenated reper-
fusion, likely due to the increased presence of 
ROS. ROS are the primary mediators of dam-
age sustained in ischemia reperfusion injury. 
There are many sources of ROS production 
during ischemia reperfusion injury in the 
liver. This review will focus on the modula-
tion of reactive oxygen species by ischemic 
preconditioning (IPC) as a means to amelio-
rate ischemia reperfusion injury. 
 
ROS MEDIATE IR INJURY 
Initially during IR injury, hepatocytes 
generate ROS from mitochondrial or cyto-
solic enzymes. Although hepatocellular-de-
rived ROS do not significantly contribute to 
cellular injury, they stimulate the release of 
nuclear protein high-mobility group box 1 
(HMGB1). HMGB1 is a damage-associated 
molecular pattern (DAMP) released from is-
chemic hepatocytes in response to cell dam-
age. This soluble factor migrates out of 
hepatocytes and binds to TLR-4 on the sur-
face of Kupffer cells, activating the sterile im-
mune response and generating additional 
ROS. The reactive oxygen intermediates re-
leased by Kupffer cells recruit CD4+ T-cells 
which activate additional ROS production by 
Kupffer cells. 
Hepatic IR injury occurs through an early 
and a late phase. Initially, Kupffer cells drive 
the early phase of hepatic injury by activating 
the inflammatory cascade. Kupffer cells, acti-
vated by HMGB1 in the vasculature (Yang et 
al., 2013), generate ROS during the early 
stages of hepatocellular damage following IR 
(Jaeschke and Farhood, 1991). Reactive oxy-
gen species integral to the early phase of IR 
injury include hydrogen peroxide and hyper-
chlorous acid, both of which are taken up by 
hepatocytes to induce necrotic pathways of 
hepatocellular death (Jaeschke and Wool-
bright, 2012). Kupffer cell activation leads to 
the secretion of pro-inflammatory cytokines 
and propagation of the sterile immune re-
sponse. 
The small amount of ROS generated by 
hepatocytes at the onset of IR injury, in con-
junction with cytokine release from Kupffer 
cells, attracts neutrophils to the site of dam-
age. Once inside the liver, neutrophils exert 
their effects during the late phase of ischemia 
reperfusion injury. Neutrophils are the key 
modulators of hepatocellular damage because 
of the large amount of additional ROS they 
produce. Neutrophil-mediated oxidant stress 
is first seen 6 to 24 hours following initiation 
of reperfusion (Hasegawa et al., 2005; 
Jaeschke et al., 1992). Neutrophils generate 
large amounts of myeloperoxidase, an en-
zyme that produces hypochlorous acid in the 
extracellular space (Thomas et al., 1983).  
Reactive oxygen species generated by 
hepatocytes during ischemia reperfusion in-
jury primarily originate from the mitochon-
dria, although ROS generation can also occur 
outside of the mitochondria. Intracellular oxi-
dant stress is generated by xanthine oxidase 
(XOD) (Jaeschke et al., 1988), although the 
role of XOD-generated ROS is thought to be 
minute compared to mitochondria-generated 
ROS, which are the primary generators of in-
tracellular ROS during IR.  The mechanisms 
by which mitochondria produce ROS are 
highly variable and depend on the presence of 
oxygen. During the ischemic phase, blood 
flow restriction causes cell metabolism to 
shift to anaerobic respiration, therefore inter-
rupting oxidative phosphorylation. The re-
striction of the electron transport chain causes 
a build-up of reduced electron carriers that are 
rapidly oxidized at the onset of reperfusion. 
The primary ROS mediating cellular injury is 
superoxide, which originates from the elec-
tron transport chain at either complex I or 
complex III. During the ischemic phase, su-
peroxide production from complex III pre-
dominates (Guzy and Schumacker, 2006); 
however, the reperfusion phase accounts for 
the majority of superoxide production via 
complex I of the electron transport chain 
(Murphy, 2009). Superoxide production at 
complex I is enhanced by the elevated 
NADH/NAD+ ratio at the onset of reperfu-
sion (Kussmaul and Hirst, 2006). The in-
crease in superoxide enhances formation of 
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hydrogen peroxide and hydroxyl radicals, ul-
timately creating a sharp surge in ROS (Datta 
et al., 2013; Klinman, 2007).  
 
IPC REDUCES MITOCHONDRIAL 
ROS PRODUCTION TO REDUCE IR 
INJURY 
IPC limits ROS formation and subse-
quently reduces ischemic injury after reperfu-
sion (Carini et al., 2001). Overall, there is a 
reduced inflammatory response in IPC, in ad-
dition to less oxidant stress following pro-
longed ischemia (Peralta et al., 2002). IPC 
strengthens antioxidant systems inside the 
cell (Schauer et al., 2003), induces heme oxy-
genase-1 (Katori et al., 2002), and promotes 
regeneration by activating p38 and MAP ki-
nases (Teoh et al., 2002). Evidence suggests 
the protective effect of IPC arises from the 
moderate post-ischemic oxidant stress pro-
duced during preconditioning (Sindram et al., 
2002; Zahler et al., 2000).  
Previous studies have demonstrated that 
even remote IPC, where ischemic precondi-
tioning is conducted at a different organ site 
than the site where injury is sustained, im-
proves perfusion and oxygenation to paren-
chymal tissue (Kanoria et al., 2006; Tapuria 
et al., 2009).  This remote IPC is correlated 
with decreased hepatocellular damage in the 
early phase of IR injury. The main cause of 
cold liver ischemia reperfusion injury appears 
to be non-parenchymal cell injury, ultimately 
leading to liver graft failure in transplantation 
(Caldwell-Kenkel, 1989; McKeown et al., 
1988). IPC protects against the loss of viabil-
ity of SECs and the activation of Kupffer 
cells, both non-parenchymal types of ische-
mia-related, oxidant-mediated cell injury 
(Arai et al., 1999). The loss of SECs during 
IR injury normally causes microcirculatory 
disturbances and propagates ischemia, lead-
ing to significant hepatic necrosis (Cywes et 
al., 1993; Takei et al., 1991). During remote 
IPC, the contralateral half of livers that did 
not undergo ischemia preconditioning also 
showed decreased non-parenchymal cell kill-
ing suggesting protection is mediated by a 
soluble factor. Indeed, later studies have 
shown that humoral factors released as a re-
sult of IPC mediate cytoprotection in the non-
parenchymal cells of the liver, leading to the 
conclusion that whole-liver IPC produces 
nearly the same protection for SECs as IPC 
with only the half-liver (Arai et al., 2001). 
In addition to loss of SECs, the activation 
of Kupffer cells is another mechanism con-
tributing to graft failure in liver transplanta-
tion (Caldwell-Kenkel et al., 1991). During 
cold liver storage and subsequent reperfusion, 
Kupffer cells are activated and produce super-
oxide radicals (Caldwell-Kenkel et al., 1995; 
Mochida et al., 1994). These radicals initiate 
inflammatory responses by promoting neutro-
phil recruitment and therefore contribute to 
graft failure (Koo et al., 1992; Lichtman and 
Lemasters, 1999; Takei et al., 1991). IPC, 
however, has been shown to decrease the 
amount of superoxide produced by individual 
Kupffer cells during cold liver IR (Arai et al., 
2001). 
The prevalence of mitochondrial-derived 
ROS in ischemia has been demonstrated 
through the use of fluorescent probes. Various 
groups measured ROS production in cells 
with and without functioning mitochondria 
under hypoxic conditions. They discovered 
that only cells equipped with functional mito-
chondria produced a significant increase in 
ROS (Chandel et al., 1998; Murphy, 2009; 
Turrens, 2003). This information suggests 
that mitochondrial-derived ROS serve as the 
primary source of ROS during reperfusion.  
Nitric oxide (NO) and its metabolites have 
been shown to protect cells following ische-
mia reperfusion injury, which may partially 
be mediated by reversible S-nitrosation of 
cysteines (Duranski et al., 2005). This mech-
anism has been used to explain cellular pro-
tection in the reperfusion phase following IPC 
(Sun et al., 2013, 2007). Reversible S-nitrosa-
tion occurring specifically at the exposed 
Cys39 in the ND3 subunit of complex I in the 
electron transport chain accounts for some of 
the cellular protection following IPC. As a 
gatekeeper for oxidative phosphorylation, 
complex I initiates the movement of electrons 
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from NADH across the mitochondrial mem-
brane to create a proton gradient. S-nitrosa-
tion of complex I causes mitochondria to be 
in a low activity conformation resulting in 
less ROS production (Chouchani et al., 2013). 
By decreasing the amount of mitochondrial-
derived ROS, IPC reduces oxidative damage 
and tissue necrosis. 
 
IPC INHIBITS HMGB1 RELEASE  
DURING IR 
HMGB1 is a DAMP that plays a pivotal 
role in coordinating the sterile immune re-
sponse during cold liver IR (Muller et al., 
2004). Hepatocytes release HMGB1 during 
IR in a ROS-dependent process that is medi-
ated by post-translational acetylation. Briefly, 
ROS generated during IR inhibit nuclear his-
tone deacetylases (HDACs). This results in 
hyperacetylation of HMGB1, which in turn 
results in HMGB1 translocation from the nu-
cleus to the cytoplasm where it can be se-
creted into the extracellular space (Evan-
kovich et al., 2010; Yu, Tang et al., 2015).  
Once in the extracellular space HMGB1 
binds to various receptors on multiple target 
cells and plays a pivotal role in coordinating 
the sterile immune response (Kang et al., 
2014). For instance, HMGB1 signals through 
the NF-κB pathway in hepatocytes and stim-
ulates the production of the proinflammatory 
cytokine TNF-α (Lotze and Tracey, 2005). In 
the later stages of the sterile immune re-
sponse, HMGB1 binds to TLR4 receptors on 
neutrophils and stimulates neutrophil extra-
cellular trap (NET) secretion which leads to 
hepatocyte death and activation of Kupffer 
cells (Huang et al., 2015). It should thus come 
as no surprise that inhibition of the TLR4 re-
ceptor during a sterile immune response is 
protective against hepatocellular injury 
(Mcdonald et al., 2015). In sum, mitochon-
drial ROS generated as a result of IR stimu-
lates the secretion of HGMB1, which in turn 
recruits immune cells and results in a local-
ized sterile immune response. 
Since HMGB1 is central in eliciting the 
sterile immune response during IR, finding 
ways to inhibit its actions could protect 
against liver injury. Indeed, inhibition of 
HMGB1 with a neutralizing antibody was 
found to significantly reduce the extent of IR-
induced liver damage in a murine model 
(Tsung et al., 2005). To take this one step fur-
ther, inhibition of mitochondrial ROS genera-
tion should inhibit HMGB1 secretion because 
secretion of HMGB1 is dependent upon intra-
cellular levels of ROS. In fact, IR-induced 
HMGB1 expression in the liver was attenu-
ated by IPC in a murine model (Garab et al., 
2014). In another study involving rat myocar-
dium, IPC was also found to reduce circulat-
ing levels of HMGB1 and protect the myocar-
dium against a sterile immune response as ev-
idenced by a smaller area of myocardial in-
farct (Zhang et al., 2013). In a human study 
on patients undergoing coronary angioplasty, 
IPC resulted in attenuation of the inflamma-
tory markers CD40L, P-selectin, and myelop-
eroxidase (Lee et al., 2005; Xu et al., 2016). 
These markers are upregulated in the presence 
of HMGB1 and are involved in immune acti-
vation and thus contribute to the sterile re-
sponse seen in IR. Taken together, these stud-
ies demonstrate the ability of IPC to inhibit 
HMGB1 release and subsequent immune ac-
tivation during preclinical models of IR (Fig-
ure 1).  
 
IPC INHIBITS EXPRESSION OF NF-ΚB 
AND PROINFLAMMATORY  
CYTOKINES DURING IR 
NF-κB is a transcription factor that plays 
a central role in cytokine production and cell 
survival (Gilmore, 2006). NF-κB is upregu-
lated in hepatocytes during IR and stimulates 
the release of several proinflammatory cyto-
kines that contribute to the sterile immune re-
sponse (Ricciardi et al., 2000; Shin et al., 
2008). Notably, the proinflammatory cyto-
kine TNF-α plays a central role in the sterile 
immune response and is responsible for a sig-
nificant portion of the liver injury associated 
with IR (Perry et al., 2011). NF-κB expression 
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Figure 1: Ischemic preconditioning (IPC) inhibits hepatocyte ROS production and reduces HMGB1 re-
lease. IPC-medaited inhibition of hepatocyte reactive oxygen specied (ROS) production results in de-
creased levels of HMGB1 and subsequent prevention of Kupffer cell activation and downstream activa-
tion of neutrophils and CD4+ T-cells. The result is protection from immune-mediated damage to sinus-
oidal endothelial cells (SECs). 
 
 
is enhanced during IR by several mecha-
nisms: HMGB1 signaling via cell surface re-
ceptors (Park et al., 2004), increased intercel-
lular Ca2+ concentrations during ischemia that 
results in the activation of protein kinase C 
which in turn activates NF-κB (Steffan et al., 
1995), stimulation of NADPH oxidase with 
subsequent ROS production during ischemia 
(Spencer et al., 2013), and accumulation of 
mitochondria-derived ROS during IR 
(Chandel et al., 2000) (Figure 2). 
Once activated, NF-κB translocates to the 
nucleus where it acts as a transcription factor 
that stimulates the production of numerous 
proinflammatory molecules. Since NF-κB 
plays such a pivotal role in the inflammatory 
response, inhibiting its actions prevents 
against tissue damage during IR. Inhibition of 
NF-κB in mice with the small molecule inhib-
itor Baicalein provided considerable protec-
tion against IR injury of the liver (Liu et al., 
2015). Several studies indicate that IPC inhib-
its NF-κB during IR and thus inhibits the pro-
duction of proinflammatory cytokines. In a 
murine model, IPC attenuated NF-κB activity 
in hepatocytes and led to a reduction in TNF–
α and ICAM-1 mRNA levels when subject to 
subsequent IR. IPC also inhibited phosphory-
lation of the NF-κB inhibitor (IκB), thereby 
prolonging its half-life and its ability to in-
hibit NF-κB. Together, these findings suggest 
that IPC inhibits NF-κB activity and the sub-
sequent production of proinflammatory cyto-
kines (Funaki et al., 2002).  
In a separate study involving rat myocar-
dium, IPC led to a similar inhibition of NF-
κB activity with a corresponding reduction in 
levels of proinflammatory cytokine mRNA 
(IL-1, IL-6, TNF-α). IPC was also found to 
protect the myocardium from IR-induced tis-
sue injury as evidenced by diminished infarct 
size as compared to a control group that did 
not undergo IPC. The authors conclude that 
inhibition of NF-κB via IPC attenuates proin-
flammatory cytokine production, which pro-
tects the myocardium from IR injury (Hiasa et 
al., 2001).  A third study involving a murine 
model similarly found that IPC inhibited NF-
κB activity, thereby attenuating TNF-α ex- 
EXCLI Journal 2017;16:483-496 – ISSN 1611-2156 
Received: January 20, 2017, accepted: March 20, 2017, published: April 07, 2017 
 
 
488 
 
Figure 2: In the absence of IPC, reactive oxygen species such as superoxide inhibit HDACs causing 
hyperacetylation of HMGB1 in the nucleus. In this form HMBG1 translocates to the cytoplasm and even-
tually enters the extracellular space to coordinate the sterile immune response. (1) IPC exerts its cyto-
protective effects by decreasing the amount of superoxide produced intracellularly, thereby disinhibiting 
HDACs from acting on HMGB1 in the nucleus. HMGB1 is then unable to move into the extracellular 
space to drive immune activation. (2) The decreased amount of HMGB1 in the vasculature reduces 
signaling through the NF-kB pathway, thereby suppressing the production of proinflammatory cytokines 
such as TNF-alpha. 
 
 
pression upon exposure to lipopolysaccha-
ride. Mice were randomly assigned to be ei-
ther controls or to undergo remote IPC in 
which blood flow to a hind limb was occluded 
with a rubber band three times for ten minutes 
each time and separated by a ten minute pe-
riod of reperfusion. Remote IPC was found to 
inhibit NF-κB activity with concomitant at-
tenuation of TNF-α expression, neutrophil ac-
cumulation, and microabscess formation in 
the liver, thus protecting the liver from subse-
quent IR insult (Shin et al., 2014). Finally, 
IPC was shown to attenuate expression of 
TNF-α and ICAM-1 in hepatocytes using a 
murine model of IR. Mice assigned to un-
dergo IPC had significantly reduced levels of 
circulating ALT and LDH than did the mice 
assigned to the sham-operated group. IPC was 
also found to inhibit neutrophil infiltration 
and the authors attribute these findings to sup-
pression of NF-κB via IPC (Li et al., 2006). 
Taken together, these studies suggest that IPC 
inhibits the activity of NF-κB, resulting in a 
reduction of proinflammatory cytokine pro-
duction, which protects the liver during IR. 
 
IPC INHIBITS KUPFFER CELL  
ACTIVATION DURING COLD IR 
Kupffer cells are tissue-specific macro-
phages that line the sinuses of the liver and 
serve as the primary source of ROS during the 
early stages of the sterile immune response. 
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The ROS and proinflammatory cytokines 
generated by Kupffer cells lead to the recruit-
ment of neutrophils which then serve as the 
primary source of ROS during the later stages 
of the sterile immune response (Jaeschke and 
Farhood, 1991). Kupffer cells are activated by 
the HMGB1 that is secreted by hepatocytes in 
response to IR (Yang et al., 2013). HMGB1 
signals through Kupffer cell TLR4 receptors 
to stimulate the production of ROS and other 
proinflammatory molecules that lead to wide-
spread tissue injury (Kupiec-Weglinski and 
Busuttil, 2005; Tsung et al., 2005). Inhibition 
of Kupffer cell activation during IR may sup-
press inflammation and thus protect the liver 
from injury. In two separate studies involving 
preclinical animal models, IPC inhibited Kup-
ffer cell activation and protected against liver 
tissue injury. In these studies, rats were sepa-
rated into two groups and underwent either 
IPC or sham surgery. IPC involved clamping 
of the hepatic artery and portal vein for five 
minutes followed by five minutes of reperfu-
sion. Upon subsequent IR insult, Kupffer cell 
activity was suppressed in the group that un-
derwent IPC as evidenced by diminished su-
peroxide production in the vicinity of the 
Kuppfer cells. In addition, IPC provided sig-
nificant protection to liver tissue. The authors 
measured the extent of tissue injury by count-
ing the number of nonviable SECs following 
IR insult and found that IPC reduced SEC 
death by more than half. The authors attribute 
this tissue preservation to Kupffer cell inacti-
vation during IPC (Arai et al., 1999, 2001). It 
is interesting to note that whereas the protec-
tion conferred by IPC during cold IR is 
thought to be the result of decreased Kupffer 
cell activity, the opposite is believed to be true 
regarding warm IR. That is the cytoprotection 
conferred by IPC during warm IR insult is 
thought to be the result of an increase in ROS. 
This sublethal burst of Kuppfer cell-derived 
ROS is thought to prime the organ for subse-
quent IR insult. Indeed, Tejima et al. (2004) 
showed that there was an increase in Kupffer 
cell derived ROS during warm IPC. Further-
more, they were able to mimic the cytoprotec-
tive effects of IPC by pretreating rat livers 
with low concentrations of hydrogen perox-
ide. In either case, it is clear that the Kuppfer 
cells play a central role in the cytoprotective 
properties of IPC. 
In another study, IPC of rat livers was 
found to inhibit TNF-α secretion from Kup-
ffer cells during IR in a process mediated by 
NO. IPC suppressed inflammation and pro-
tected the lungs and the liver from tissue in-
jury. The authors showed that Kupffer cell in-
hibition with gadolinium chloride inhibited 
secretion of TNF-α during IR and attenuated 
the harmful inflammatory response. When 
TNF-α was reintroduced into the tissue, the 
anti-inflammatory effects of gadolinium chlo-
ride were reversed. These findings suggest 
that Kupffer cells are the primary source of 
TNF-α immediately following IR. The au-
thors then show that IPC provides similar in-
hibition of TNF-α and suppression of the in-
flammatory response seen with gadolinium 
chloride. This suggests that IPC protects 
against tissue injury by inhibiting the secre-
tion of TNF-α from Kupffer cells. Finally, the 
authors showed that the protective effects 
conferred by IPC are lost when NO synthesis 
is inhibited, which indicates that the process 
is mediated by NO. The authors conclude that 
IPC inhibits TNF-α secretion by Kupffer cells 
in a NO-dependent process. This supresses a 
harmful inflammatory response induced by 
IR and protects the liver and lungs against in-
jury (Peralta et al., 1999). Taken together, 
these findings seem to indicate that IPC inhib-
its Kupffer cell activity and in doing so atten-
uates IR-induced inflammation.   
 
IPC INHIBITS CD4+ T-CELL  
RECRUITMENT AND ACTIVATION 
DURING IR 
Activated Kupffer cells secrete ROS and 
proinflammatory cytokines such as IL-6 and 
TNF-α that recruit CD4+ T-cells to the the 
liver during IR. Kupffer cell cytokines also 
upregulate T-cell specific adhesion molecules 
on SECs to facilitate T-cell recruitment to the 
site of insult (Jaeschke and Farhood, 1991). 
Once in the liver, activated CD4+ T-cells can 
reciprocally activate Kupffer cells in a CD-
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40-dependent process thus leading to a self-
perpetuating inflammatory response 
(Hanschen et al., 2008). CD4+ T-cells are re-
sponsible for significant tissue injury during 
IR and inhibition of CD4+ T-cell activation 
could have therapeutic potential (Shen et al., 
2009).  
Several studies have implicated IPC in 
CD4+ T-cell inhibition during IR. In one 
study, mice were divided into two groups. 
One group underwent 30 minutes of renal IPC 
while the other group underwent a sham op-
eration. Five days after the operation, leuko-
cytes were purified from the spleens of each 
group and injected into the circulation of T-
cell deficient mice. Upon exposure to IR in-
sult, the mice that received leukocytes from 
IPC mice showed markedly less kidney injury 
than the mice that received leukocytes from 
the sham-operated group. This study suggests 
that IPC inhibits the capacity of leukocytes to 
cause tissue injury during subsequent bouts of 
IR. Although the authors did not elucidate the 
specific populations of leukocytes that were 
affected by IPC, they were able to rule out 
neutrophils and macrophages since their infil-
tration into the kidney did not provide any tis-
sue protection (Burne-Taney et al., 2006).  
A second study in a murine kidney model 
found that short bursts of IPC resulted in a sig-
nificant reduction in the activity of the stress-
activated mitogen activated protein (MAP) 
kinases JNK and p38, which was accounted 
for by inactivation of upstream MAP kinase 
kinases. JNK and p38 have long been known 
to serve as growth and survival factors and 
thus it is somewhat counterintuitive that a re-
duction in these mediators is actually cytopro-
tective during IR. Briefly, IR insult causes ox-
idative stress that stimulates increased expres-
sion of the stress-activated mediators JNK 
and p38. These mediators in turn stimulate ex-
pression of specific adhesion molecules on 
the cell surface that assist in the recruitment 
of leukocytes to the site of injury (Read et al., 
1997). Once recruited to the target site, the 
leukocytes propagate the sterile immune re-
sponse by secreting proinflammatory media-
tors that lead to inflammation and subsequent 
tissue damage (Xia et al., 1995). The authors 
of the study argue that inhibition of this path-
way resulted in diminished cytokine-induced 
leukocyte-endothelial interactions, which 
prevented recruitment of leukocytes to the site 
of insult, thus preventing leukocyte-induced 
tissue damage (Park et al., 2001). IPC thus ap-
pears to inhibit leukocyte recruitment during 
IR.  
In a third study, human subjects undergo-
ing elective cruciate ligament surgery were 
divided into a group that received IPC and a 
group that did not. The group that underwent 
IPC was subject to three five-minute rounds 
of tourniquet-induced ischemia separated by 
a five-minute period of reperfusion. Both 
groups were then subject to one hour of tour-
niquet-induced ischemia during surgery. Af-
ter surgery, the group that underwent IPC ex-
hibited marked inhibition of proinflammatory 
cytokine production by CD4+ T-cells and thus 
attenuated an inflammatory immune re-
sponse. In particular, circulating levels of the 
proinflammatory cytokine IL-2 produced by 
CD4+ T-cells was significantly reduced in the 
group that underwent IPC (Sullivan et al., 
2009).  
IPC also affects the activity of immuno-
suppressing regulatory T cells (Tregs). In two 
separate studies involving murine models of 
renal IPC, IPC activated Tregs which reduced 
immune-mediated inflammation and pro-
tected against tissue injury. In particular, Tregs 
harvested from mice that underwent either 
IPC or sham surgery were injected into naïve 
mice. Those animals that received Tregs from 
donor mice that underwent IPC exhibited sim-
ilar tissue protection and suppression of in-
flammation, indicating that IPC-activated 
Tregs protect against subsequent IR insult. 
(Cho et al., 2010; Kinsey et al., 2010). Taken 
together, this data suggests that IPC nega-
tively regulates the immune response during 
IR and thus protects against tissue damage. 
 
IPC IMPROVES LIVER FUNCTION 
FOLLOWING IR INJURY IN HUMANS 
In humans, the efficacy of IPC can be 
measured several ways post-transplantation.  
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Quantifiable assays to measure the degree of 
ischemic injury in the liver include serum bil-
irubin, aspartate transaminase (AST), and al-
anine aminotransferase (ALT). Other 
measures such as lactic acid are also used to 
measure liver function indirectly. Lactic acid 
is a product of cell metabolism and can accu-
mulate in states of hypoxia. In the context of 
liver transplantation, serum lactate levels will 
increase in conjunction with the severity of 
hypoxia. Normalization of blood lactate lev-
els can indicate recovery of liver metabolic 
capacities in the postoperative setting of liver 
transplantation (De Gasperi et al., 1997).  
In studies of IPC in human liver transplan-
tation, AST and ALT levels are used to indi-
cate protective effects due to IPC. Transami-
nase levels following liver transplantation are 
the most reliable markers of hepatocellular in-
jury. Of the cellular markers, serum AST is 
most tightly correlated with the degree of is-
chemic injury to the liver (Clavien et al., 
2000).  The reduction of AST levels in the pa-
tient is associated with a reduction in cell 
death during the late preconditioning phase of 
IPC (Jassem et al., 2009). IPC has been shown 
to decrease levels of circulating ALT, AST, 
and LDH (Koti et al., 2003; Liu et al., 2014; 
Ricciardi et al., 2001; Sindram et al., 2002; 
Zhu et al., 2014). 
In human liver transplantation preceded 
by IPC, postoperative AST and ALT levels 
were significantly lower than that of the con-
trol group (Clavien et al., 2003).  When used 
with allografts of deceased donor liver for 
transplantation, IPC protects the organ by re-
ducing AST levels in the recipient. Three days 
after transplant, AST levels were lower in pa-
tients who received an allograft treated with 
IPC prior to transplantation than those who 
received an allograft that was not precondi-
tioned.  Patients that received a liver allograft 
pretreated with IPC also demonstrated lower 
serum lactate levels compared to untreated 
one day post-transplantation (Jassem et al., 
2009). 
 
LIMITATIONS OF IPC 
IN THE CLINICAL SETTING 
Although IPC initially leads to a favorable 
reduction in numerous biomarkers for liver 
damage in the early stages of IR, in the long 
term it does not appear to have any effect on 
overall morbidity and mortality following 
liver resection or transplantation (Zhu et al., 
2014). During liver resection circulation to 
the organ is temporarily interrupted which in-
creases the risk for IR injury when blood flow 
is restored.  A randomized control trial in-
volving 84 patients that underwent major liver 
resection found no clinical benefit to IPC 
prior to resection using an intermittent Pringle 
maneuver (Scatton et al., 2011). In a similar 
study involving 100 patients, IPC prior to 
liver resection also using a Pringle maneuver 
did not provide any clinical benefit in terms 
of length of hospitalization, morbidity, or 
mortality (Ye et al., 2014). A study involving 
22 participants undergoing adult-to-adult liv-
ing liver transplantation did not find any clin-
ically significant benefit for the donor nor the 
recipient in terms of morbidity or mortality 
(Andreani et al., 2010). Although another trial 
involving 47 whole liver transplantations 
from deceased donors found that IPC pre-
vented hepatocellular necrosis, this did not 
appear to provide any clinically significant 
benefit for the patient (Cescon et al., 2006). A 
metaanalysis of 11 randomized control trials 
involving 669 patients that underwent liver 
resection also failed to find any statistically 
significant difference in morbidity or mortal-
ity rates among study participants (O’Neill et 
al., 2013). Thus, although it is well docu-
mented that IPC provides early protection 
against IR by attenuating mitochondrial ROS 
production and thus sparing hepatocytes in 
the early stages of IR injury, there does not 
appear to be any convincing evidence that 
IPC provides any clinically demonstrable 
benefit in reducing patient morbidity or mor-
tality following liver resection or transplanta-
tion. 
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It has been suggested that the discrepancy 
between preclinical and human modeling of 
IPC efficacy may be due to variable timing 
and type of vascular occlusion in IPC proto-
cols in human trials, as well as the number of 
cirrhotic and steatotic livers included in the 
human trials.  Importantly, although changes 
in mortality are not observed in the human tri-
als performed to date, other beneficial posi-
tive outcomes such as reduced operative 
blood loss are improved in the setting of IPC 
(Simillis et al., 2016). Taken together, these 
data identify a need for further randomized 
clinical trials to compare length of ischemia 
during preconditioning, methods of vascular 
occlusion, and subtypes of patients who may 
benefit most from IPC. 
 
CONCLUSION 
IR injury is a significant source of mor-
bidity and mortality following liver transplan-
tation. When circulation is restored to a newly 
transplanted liver, the reintroduction of oxy-
gen into the tissue sets off a sterile immune 
response that can result in widespread tissue 
injury and transplant rejection. IPC has 
emerged as a means to mitigate such tissue 
damage and its ability to attenuate IR-induced 
tissue injury in the laboratory has been well 
documented in the literature. However, alt-
hough IPC leads to a favorable reduction in 
biomarkers for tissue injury in the laboratory, 
these findings have not been successfully 
translated into clinical practice, as there is 
limited evidence that IPC has an influence on 
post-transplantation morbidity and mortality. 
Future work should be aimed at finding a way 
to translate these promising laboratory find-
ings into clinical practice. 
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